Emily Williams

Senior director, Communications @SatellosBio | #livingdonor | #ALD & #amyloidosis family | Tweets are my own.

[Intellia Therapeutics @intelliatx]

We have initiated a rolling Biologics License Application (BLA) submission to the @FDA to seek approval for our lead candidate as a potential one-time treatment for hereditary angioedema (#HAE). Read the press release here: https://t.co/js8lE5nlb8

[Satellos Bioscience @SatellosBio]

Satellos announced today that its common shares have been approved for listing on the Nasdaq Stock Market LLC and have commenced trading under the ticker “MSLE.” The Company’s common shares continue to trade on TSX under “MSCL.”

More here: https://t.co/1WlXfOYak5

$MSLE $MSCL #MuscleRegeneration

[Satellos Bioscience @SatellosBio]

Satellos is heading to San Francisco for the @jpmorgan Healthcare Conference next week. With BASECAMP, our Phase 2 trial of SAT-3247 in children with #Duchenne, now underway, we look forward to connecting with industry leaders and the investment community to discuss the year ahead.

#JPM2026 #MuscleRegeneration $MSCL $MSCLF

[Satellos Bioscience @SatellosBio]

The reason behind the research.

#MuscleRegeneration #Duchenne $MSCL $MSCLF

Learn more at https://t.co/kf4RYZgeam

[Satellos Bioscience @SatellosBio]

A question that sits at the center of our work.

Explore more at https://t.co/kf4RYZgeam.

#MuscleRegeneration #Duchenne $MSCL $MSCLF

[Emily Williams @EmDashily]

A moment worth celebrating. 

#MuscleRegeneration

[Satellos Bioscience @SatellosBio]

#Duchenne News: The @US_FDA,  as well as other global regulatory agencies, have cleared Satellos to initiate a Phase 2 study of SAT-3247 in ambulatory children with Duchenne muscular dystrophy. Full details here: https://t.co/dse66BTkMe

#MuscleRegeneration $MSCL $MSCLF

[Satellos Bioscience @SatellosBio]

Satellos has reported its Q3 2025 financial results and announced the appointment of Mark Nawacki to its Board of Directors. Read the full release: https://t.co/8FgySAUyju

#MuscleRegeneration #Duchenne $MSCL $MSCLF

[Emily Williams @EmDashily]

Take a moment to read Charlie's story.

[Satellos Bioscience @SatellosBio]

Families like Charlie’s remind us what it means to live with #Duchenne — the strength it takes, the hope they hold, and the future they deserve.

Read Charlie’s story: https://t.co/YD9NHnj3jv

#MuscleRegeneration #SatellosStories $MSCLF $MSCL
(Sound on 🎧)

[Satellos Bioscience @SatellosBio]

#Duchenne News: Today, Satellos announced that the first patient has been dosed in LT-001, an open-label, long-term follow-up study of SAT-3247 in adult males with Duchenne muscular dystrophy. Full details here: https://t.co/QziVxknqqV

#MuscleRegeneration $MSCL $MSCLF

[Satellos Bioscience @SatellosBio]

In #Duchenne muscular dystrophy, the body’s natural muscle repair system breaks down. Satellos is studying an investigational approach designed to restore muscle regeneration from within.

Watch this short video to see how: https://t.co/YxdcmIB9rn

#DecodingDuchenne #MuscleRegeneration $MSCL $MSCLF

[Satellos Bioscience @SatellosBio]

“In our family, we dare to dream of a different kind of future for Charlie, one where Duchenne exists in a small, dark corner of a big, beautiful life.” -Jennifer, Charlie’s mom

On World Duchenne Awareness Day, we celebrate families like Charlie’s — the true heart of care.💙

https://t.co/hfQNnSos63

#WDAD2025 #TheHeartofCare #DuchenneAwarenessDay @DuchenneDay $MSCL $MSCLF

[Satellos Bioscience @SatellosBio]

Satellos CEO Frank Gleeson and CMO Dr. Wildon Farwell joined a fireside chat this morning at the Cantor Fitzgerald Global Healthcare Conference. They shared updates on Satellos’ progress, our focus on advancing SAT-3247 for #Duchenne, and the road ahead.

Replay now available: https://t.co/90jhIJCBK2

#MuscleRegeneration #CantorHealthcare $MSCL $MSCLF

[Satellos Bioscience @SatellosBio]

We’re honored to support the @JettFoundation annual World Duchenne Awareness Day event tomorrow in Quincy, MA. Two of our Satellos team members will be there, and we’re looking forward to connecting with families, advocates, and everyone who makes this community so special. 💙

#StrongerThanDuchenne
#JettFoundationWDAD
#wdad2025
$MSCL $MSCLF

[Satellos Bioscience @SatellosBio]

In #Duchenne muscular dystrophy, the signal that tells muscle stem cells how to repair and regenerate muscle is missing.

This short clip explains what Satellos uncovered — and how we’re studying ways to address that missing signal.

Learn more: https://t.co/VWPK3vTt22

#DecodingDuchenne #MuscleRegeneration $MSCL $MSCLF

[Emily Williams @EmDashily]

Our team @SatellosBio uncovered why muscle repair fails — and how we’re working to restore it in #Duchenne.

[Satellos Bioscience @SatellosBio]

(🔊sound on) In #Duchenne muscular dystrophy, muscles break down faster than they can repair. Satellos discovered why: the repair process is disrupted. We’re working on a way to restart the body’s natural repair system.

👉 Learn more about we're approaching muscle regeneration: https://t.co/IC7PKYVHGQ

#DecodingDuchenne #MuscleRegeneration $MSCL $MSCLF

[Emily Williams @EmDashily]

$MSCL $MSCLF

[Satellos Bioscience @SatellosBio]

We look forward to connecting with the investment community this September at several leading health care conferences:

📍 Wells Fargo Healthcare Conference
1x1 Meetings | Wed., Sept. 3 | Boston

📍 Cantor Fitzgerald Global Healthcare Conference
Fireside Chat & 1x1 Meetings | Fri., Sept. 5, 10:55 a.m. ET | New York

📍 H.C. Wainwright Global Investment Conference
1x1 Meetings | Tues., Sept. 9 | New York

📍 Morgan Stanley Global Healthcare Conference
Fireside Chat & 1x1 Meetings | Wed., Sept. 10, 9:15 a.m. ET | New York

More details here: https://t.co/UllXRkvsWr

[Satellos Bioscience @SatellosBio]

Our muscles are like a road — daily wear creates cracks. Satellite cells are the repair crews, always ready to respond.

Activate. Repair. Repeat.

It’s how healthy muscle regenerates. In #Duchenne muscular dystrophy, that cycle breaks down over time. That’s where our research begins. Learn more at https://t.co/A3yjYzeXmc.

#MuscleRegeneration $MSCL $MSCLF

[Satellos Bioscience @SatellosBio]

$MSCL News: Satellos announces its second quarter financial results and company updates. Read the press release: https://t.co/oalLxaoX3b

#Duchenne #MuscleRegeneration $MSCLF

[Satellos Bioscience @SatellosBio]

(🔊sound on) There’s a reason muscle fails to repair in #Duchenne. It’s not just the damage. It’s a breakdown in the regenerative process — a fundamental mechanism, long misunderstood. We uncovered how it’s supposed to work. And now, we’re advancing a way to correct it. 🔗https://t.co/A3yjYzeXmc

Regenerating muscle from within. #MuscleRegeneration $MSCL $MSCLF

[Satellos Bioscience @SatellosBio]

Satellos will present at Canaccord Genuity’s (@CG_Driven) 45th Annual Growth Conference, taking place Aug. 13–14 at the InterContinental Boston.

📅 Aug. 13 | ⏰12:30–12:55 p.m. ET | 📍Abigail Adams C

We’ll also be available for one-on-one investor meetings. More here: https://t.co/dFWfz2mCPe $MSCL $MSCLF